For following the competition: what moved in each program, several studies read as one move.
- Anti-GFRAL Monoclonal Antibody NGM120
- Anti-ILT2/Anti-ILT4 Monoclonal Antibody NGM707
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add NGM Biopharmaceuticals to watchlistEvery Monday by email · turn it off any timePro · free during the beta